CLEVIPIDINE

CLEVIPIDINE was reported 294 times

CLEVIPIDINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SHUNT BLOOD FLOW EXCESSIVE 2 0.1250
1 CARDIAC SEPTAL DEFECT RESIDUAL SHUNT 1 0.1000
2 URINARY LIPIDS PRESENT 1 0.0833
3 VENTILATION PERFUSION MISMATCH 23 0.0819
4 VOCAL FOLD IMMOBILITY 1 0.0526
5 VENOUS OXYGEN SATURATION DECREASED 1 0.0141
6 OCULAR ISCHAEMIC SYNDROME 1 0.0118
7 RESPIRATORY GAS EXCHANGE DISORDER 4 0.0108
8 WITHDRAWAL HYPERTENSION 2 0.0099
9 INTERSTITIAL LUNG ABNORMALITY 1 0.0088
10 PRODUCT DOSAGE FORM CONFUSION 1 0.0083
11 VASCULAR RESISTANCE SYSTEMIC DECREASED 1 0.0075
12 CRANIAL NERVE PALSIES MULTIPLE 1 0.0071
13 BASILAR ARTERY OCCLUSION 1 0.0060
14 TACHYPHYLAXIS 2 0.0057
15 BASILAR ARTERY THROMBOSIS 1 0.0056
16 CEREBRAL MASS EFFECT 2 0.0055
17 PROCEDURAL HYPERTENSION 1 0.0053
18 ABNORMAL CLOTTING FACTOR 1 0.0049
19 INFUSION SITE PHLEBITIS 1 0.0044
20 DRUG LABEL CONFUSION 1 0.0040
21 EXTRAVASATION 13 0.0032
22 PO2 DECREASED 3 0.0026
23 PENILE HAEMORRHAGE 2 0.0025
24 OPERATIVE HAEMORRHAGE 1 0.0022
25 BLOOD PHOSPHORUS ABNORMAL 1 0.0021
26 INFUSION SITE VESICLES 1 0.0019
27 EPIGLOTTITIS 1 0.0018
28 BLOOD PRESSURE INADEQUATELY CONTROLLED 11 0.0018
29 BLOOD MAGNESIUM ABNORMAL 1 0.0018
30 CATHETER SITE INFLAMMATION 1 0.0018
31 INFUSION SITE EXTRAVASATION 10 0.0016
32 EYE ROLLING 1 0.0014
33 PULMONARY ARTERY THROMBOSIS 1 0.0013
34 LABORATORY TEST INTERFERENCE 1 0.0013
35 BLOOD AMYLASE INCREASED 2 0.0012
36 NODAL ARRHYTHMIA 1 0.0012
37 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
38 BRAIN STEM INFARCTION 1 0.0010
39 PERIODONTITIS 2 0.0009
40 KETOSIS 1 0.0009
41 PRODUCT NAME CONFUSION 1 0.0009
42 INFECTION SUSCEPTIBILITY INCREASED 2 0.0009
43 INCISION SITE PAIN 1 0.0009
44 HYPERTENSIVE EMERGENCY 1 0.0008
45 INFUSION SITE WARMTH 1 0.0008
46 PRODUCT CONTAMINATION PHYSICAL 2 0.0008
47 BLOOD BILIRUBIN ABNORMAL 1 0.0008
48 DRUG TITRATION ERROR 2 0.0008
49 PROTEIN TOTAL ABNORMAL 1 0.0008
50 PRODUCT LABEL ISSUE 5 0.0007
51 ECHOCARDIOGRAM ABNORMAL 1 0.0007
52 HYPERTRIGLYCERIDAEMIA 4 0.0007
53 INFUSION SITE INDURATION 1 0.0007
54 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
55 INFUSION SITE SWELLING 4 0.0006
56 HYPOXIA 22 0.0006
57 VENOUS OCCLUSION 1 0.0005
58 DRUG DOSE TITRATION NOT PERFORMED 1 0.0005
59 LIPIDS INCREASED 1 0.0005
60 VENOUS THROMBOSIS LIMB 1 0.0005
61 AORTIC DISSECTION 2 0.0005
62 ILEUS 6 0.0005
63 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
64 PRODUCT PACKAGING CONFUSION 1 0.0004
65 VASODILATATION 1 0.0004
66 LIPASE INCREASED 3 0.0004
67 LUNG OPACITY 1 0.0004
68 BLOOD POTASSIUM ABNORMAL 1 0.0004
69 BLOOD SODIUM INCREASED 1 0.0004
70 PRODUCT LABEL CONFUSION 2 0.0003
71 HYPERLIPIDAEMIA 4 0.0003
72 OXYGEN SATURATION DECREASED 18 0.0003
73 INFUSION SITE PRURITUS 1 0.0003
74 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
75 DRUG ADMINISTRATION ERROR 9 0.0003
76 THROMBOPHLEBITIS 1 0.0003
77 EMBOLIC STROKE 1 0.0003
78 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
79 CAROTID ARTERY OCCLUSION 1 0.0003
80 POST PROCEDURAL COMPLICATION 5 0.0003
81 ORGAN FAILURE 1 0.0002
82 RHINITIS 2 0.0002
83 NO THERAPEUTIC RESPONSE 3 0.0002
84 BRADYCARDIA 13 0.0002
85 ACCIDENTAL EXPOSURE 1 0.0002
86 INFUSION SITE ERYTHEMA 2 0.0002
87 PULMONARY CONGESTION 3 0.0002
88 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
89 PULSE ABSENT 1 0.0002
90 HYPERVOLAEMIA 1 0.0002
91 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
92 PRODUCT COMPLAINT 5 0.0002
93 PRODUCT COLOUR ISSUE 1 0.0002
94 PETECHIAE 2 0.0002
95 TACHYCARDIA 16 0.0002
96 MENTAL STATUS CHANGES 5 0.0002
97 HYPERTENSIVE CRISIS 2 0.0002
98 CORONARY ARTERY BYPASS 1 0.0002
99 CARDIOMEGALY 2 0.0002
100 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
101 POOR QUALITY DRUG ADMINISTERED 1 0.0002
102 GINGIVAL BLEEDING 2 0.0001
103 INFARCTION 1 0.0001
104 RESPIRATORY DISTRESS 4 0.0001
105 BLOOD TEST ABNORMAL 2 0.0001
106 ATRIAL FIBRILLATION 13 0.0001
107 TROPONIN INCREASED 1 0.0001
108 ACIDOSIS 1 0.0001
109 PROCEDURAL COMPLICATION 1 0.0001
110 FOOD ALLERGY 1 0.0001
111 HAEMOLYSIS 1 0.0001
112 APNOEA 1 0.0001
113 ACUTE MYELOID LEUKAEMIA 2 0.0001
114 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
115 ENCEPHALOPATHY 3 0.0001
116 EMBOLISM 1 0.0001
117 HYPOTENSION 24 0.0001
118 UNRESPONSIVE TO STIMULI 3 0.0001
119 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
120 GROIN PAIN 1 0.0001
121 CEREBRAL HAEMORRHAGE 4 0.0001
122 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
123 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
124 PRESCRIBED OVERDOSE 2 0.0001
125 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
126 APHASIA 3 0.0001
127 SUBARACHNOID HAEMORRHAGE 1 0.0001
128 DELIRIUM 3 0.0001
129 POST PROCEDURAL HAEMORRHAGE 1 0.0001
130 CEREBRAL INFARCTION 2 0.0001
131 GENERALISED OEDEMA 1 0.0001
132 INFUSION SITE PAIN 1 0.0001
133 PERIPHERAL COLDNESS 1 0.0001
134 SINUS TACHYCARDIA 1 0.0001
135 CARDIOGENIC SHOCK 1 0.0001
136 FLUID OVERLOAD 1 0.0001
137 THERAPY NON-RESPONDER 3 0.0001
138 DRUG DISPENSING ERROR 1 0.0001
139 CYANOSIS 1 0.0001
140 ULCER 1 0.0001
141 VENTRICULAR TACHYCARDIA 1 0.0001
142 BLOOD PRESSURE DECREASED 4 0.0001
143 COAGULOPATHY 1 0.0001
144 BLOOD UREA INCREASED 1 0.0001
145 CIRCULATORY COLLAPSE 1 0.0001
146 HEART RATE DECREASED 2 0.0001
147 GASTRIC ULCER 1 0.0001
148 CARDIAC FAILURE 4 0.0000
149 PRODUCT PHYSICAL ISSUE 1 0.0000
150 PRODUCT ADMINISTRATION ERROR 1 0.0000
151 RENAL FAILURE ACUTE 2 0.0000
152 FEBRILE NEUTROPENIA 3 0.0000
153 PULMONARY OEDEMA 2 0.0000
154 ARRHYTHMIA 2 0.0000
155 BLOOD PRESSURE FLUCTUATION 1 0.0000
156 PRESYNCOPE 1 0.0000
157 HEART RATE INCREASED 4 0.0000
158 EPISTAXIS 3 0.0000
159 NO ADVERSE EVENT 7 0.0000
160 PANCREATITIS 2 0.0000
161 PANCYTOPENIA 2 0.0000
162 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
163 LIVER FUNCTION TEST ABNORMAL 1 0.0000
164 ACUTE MYOCARDIAL INFARCTION 1 0.0000
165 PLEURAL EFFUSION 2 0.0000
166 EPILEPSY 1 0.0000
167 DYSPHAGIA 3 0.0000
168 DEEP VEIN THROMBOSIS 2 0.0000
169 BLOOD CREATININE INCREASED 2 0.0000
170 INFUSION RELATED REACTION 2 0.0000
171 URINARY RETENTION 1 0.0000
172 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
173 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
174 NEOPLASM PROGRESSION 1 0.0000
175 HYPERKALAEMIA 1 0.0000
176 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
177 RESTLESSNESS 1 0.0000
178 DYSARTHRIA 1 0.0000
179 COLITIS 1 0.0000
180 BLOOD PRESSURE INCREASED 4 0.0000
181 ACUTE KIDNEY INJURY 4 0.0000
182 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
183 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
184 DISORIENTATION 1 0.0000
185 CARDIAC ARREST 2 0.0000
186 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
187 RENAL IMPAIRMENT 2 0.0000
188 PRODUCT QUALITY ISSUE 3 0.0000
189 RENAL DISORDER 1 0.0000
190 PULMONARY EMBOLISM 2 0.0000
191 HAEMOGLOBIN DECREASED 2 0.0000
192 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
193 DRUG INEFFECTIVE 24 0.0000
194 ANAPHYLACTIC REACTION 1 0.0000
195 MEDICATION ERROR 1 0.0000
196 THROMBOCYTOPENIA 2 0.0000
197 CEREBROVASCULAR ACCIDENT 3 0.0000
198 CONVULSION 1 0.0000
199 SEIZURE 2 0.0000
200 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
201 NEUTROPENIA 2 0.0000
202 PYREXIA 5 0.0000
203 HYPERTENSION 3 0.0000
204 RESPIRATORY FAILURE 1 0.0000
205 UNDERDOSE 1 0.0000
206 AGITATION 1 0.0000
207 CARDIAC FAILURE CONGESTIVE 1 0.0000
208 THROMBOSIS 1 0.0000
209 URTICARIA 2 0.0000
210 MYOCARDIAL INFARCTION 2 0.0000
211 BLOOD GLUCOSE INCREASED 2 0.0000
212 ANAEMIA 2 0.0000
213 OFF LABEL USE 9 0.0000
214 SYNCOPE 1 0.0000
215 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
216 ABDOMINAL DISTENSION 1 0.0000
217 RASH 4 0.0000
218 SEPSIS 1 0.0000
219 INCORRECT DOSE ADMINISTERED 2 0.0000
220 CHILLS 1 0.0000
221 OEDEMA PERIPHERAL 1 0.0000
222 INJECTION SITE ERYTHEMA 1 0.0000
223 RENAL FAILURE 1 0.0000
224 DEHYDRATION 1 0.0000
225 NAUSEA 5 0.0000
226 CONFUSIONAL STATE 1 0.0000
227 TREMOR 1 0.0000
228 COVID-19 1 0.0000
229 HYPERSENSITIVITY 1 0.0000
230 DYSPNOEA 3 0.0000
231 ANXIETY 1 0.0000
232 DEATH 3 0.0000
233 CONDITION AGGRAVATED 1 0.0000
234 PAIN 2 0.0000
235 DIARRHOEA 2 0.0000
236 PNEUMONIA 1 0.0000
237 PRURITUS 1 0.0000
238 MALAISE 1 0.0000
239 VOMITING 1 0.0000